Risedronate Sodium

CAS 115436-72-1 4 API suppliersSmall Molecule

Overview

Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It works by inhibiting bone resorption and modifying the bone turnover cycle.

API suppliers (4)

Suppliers of Risedronate Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India3Netherlands1

3 of 4 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

Bone DiseasesOsteoporosisPaget's Disease
Verified Supplier Partner

Do you supply Risedronate Sodium? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.